, Tracking Stock Market Picks
Enter Symbol:
Medidata Solutions (MDSO) [hlAlert]

up 315.79 %

Medidata Solutions (MDSO) rated Buy with price target $32 by Auriga U.S.A

Posted on: Wednesday,  Mar 16, 2011  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy Medidata Solutions (NASDAQ: MDSO) on 03/16/2011. Previously Auriga U.S.A rated Buy Medidata Solutions (NASDAQ: MDSO) on 12/17/2010.,
when the stock price was $11.46. Since then, Medidata Solutions has gained 315.79% as of 01/15/2016's recent price of $47.65.
If you would have followed the previous Auriga U.S.A's recommendation on MDSO, you would have gained 315.79% of your investment in 1855 days.

Medidata Solutions, Inc. is engaged in provision of hosted clinical development solutions. The Company?s solutions include software and services that enable organizations to systematically design protocols, capture, manage and report clinical data and analyze the results of that data. Its customers include pharmaceutical, biotechnology and medical device companies, academic institutions, contract research organizations (CROs) and other organizations engaged in clinical trials. Its solutions allow its customers to enhance clinical results by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development, CRO negotiation, investigator contracting, the capture and management of clinical trial data and the analysis, and reporting of that data. On March 17, 2008, the Company acquired Fast Track Systems, Inc., a provider of clinical trial planning solutions, including software, contracting data and professional services.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/16/2011 8:25 AM Buy
11.55 16.00
as of 12/30/2011
1 Week up  1.06 %
1 Month up  7.88 %
3 Months up  32.29 %
1 YTD down  -8.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2010 8:25 AM Buy
11.46 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy